Skip to main content
Log in

Renal Disposition of Recombinant Human Interleukin-11 in the Isolated Perfused Rat Kidney

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To clarify the mechanism of the renal clearance of recombinant human interleukin-11 (rhIL-11), we investigated the renal disposition characteristics of rhIL-11 in the perfused rat kidney.

Methods. The disposition characteristics of 111In-labeled rhIL-11 were analyzed using a single-pass indicator dilution technique and statistical moment analysis in the perfused rat kidney under filtering and nonfiltering conditions.

Results. Steady-state distribution volume (V d ) calculated from the venous outflow patterns of rhIL-11 at the doses of 0.3 to 10 μg/kidney was between 0.35 and 0.40 ml/g kidney. However, V d at the highest dose decreased to a value almost identical to that of bovine serum albumin, suggesting that there is a reversible and saturable interaction between the capillary wall and rhIL-11 molecule. In filtering kidney, a remarkable accumulation of rhIL-11 was observed while its urinary excretion was highly restricted at all doses. In nonfiltering kidney, rhIL-11 showed a decreased but still significant renal uptake. Taken together, the marked renal uptake of rhIL-11 may be explained by both efficient tubular reabsorption and significant uptake from the capillary side. These processes were not saturable within the tested dose range. These characteristics of rhIL-11 are likely based on non-specific electrostatic interaction with the tissues due to its cationic charge in the cytokine.

Conclusions. The renal disposition processes of rhIL-11 were clarified at organ level in a quantitative manner. These findings agree well with previous observations in an in vivo disposition study in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. T. Maack, V. Johnson, S. T. Kau, J. Figueiredo, and D. Sigulem. Kidney Int. 16:251–270 (1979).

    PubMed  Google Scholar 

  2. R. Rabkin, M. P. Ryan, and W. C. Duckworth. Diabetologica 27:351–357 (1984).

    Google Scholar 

  3. A. Takagi, H. Masuda, Y. Takakura, and M. Hasuda. J. Pharmacol. Exp. Ther. 275:537–543 (1995).

    PubMed  Google Scholar 

  4. K. Mihara, T. Hojo, M. Fujikawa, Y. Takakura, H. Sezaki, and M. Hashida. Pharm. Res. 10:823–827 (1993).

    PubMed  Google Scholar 

  5. D. J. Hnatowich, W. W. Layne, and R. L. Childs. Int. J. Appl. Radiat. Isot. 33:327–332 (1982).

    PubMed  Google Scholar 

  6. J. M. Nishiitsutsuji-Uwo, B. D. Ross, and B. D. Krebs. Biochem. J. 103:852 (1967).

    PubMed  Google Scholar 

  7. K. Yamaoka, T. Nakagawa, and T. Uno. J. Pharmacokinet. Biopharm. 6:547–558 (1978).

    PubMed  Google Scholar 

  8. T. Kakutani, K. Yamaoka, M. Hashida, and H. Sezaki. J. Pharmacokinet. Biopharm. 13:609–631 (1985).

    PubMed  Google Scholar 

  9. F. H. Epstein, J. T. Brosnan, J. D. Tange, and B. D. Ross. Am. J. Physiol. 243:F284–F292 (1982).

    PubMed  Google Scholar 

  10. S. Hall and M. Rowland. J. Pharmacol. Exp. Ther. 232:263–268 (1985).

    PubMed  Google Scholar 

  11. D. Alcorn, K. R. Emslie, B. D. Ross, G. B. Ryan, and J. D. Tange. Kidney Int. 19:638–647 (1981).

    PubMed  Google Scholar 

  12. J. R. Duncan, and M. J. Welch. J. Nucl. Med. 34:1728–1738 (1993).

    PubMed  Google Scholar 

  13. D. C. Kim, B. Reitz, D. F. Carmichael, and D. C. Blowdow. J. Pharam. Sci. 84:575–580 (1995).

    Google Scholar 

  14. T. Maack. Am. J. Med. 58:57–64 (1975).

    PubMed  Google Scholar 

  15. F. A. Carone, D. R. Peterson, S. Oparil, and T. N. Pullman. Kidney Int. 16:271–278 (1979).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takagi, A., Yabe, Y., Oka, Y. et al. Renal Disposition of Recombinant Human Interleukin-11 in the Isolated Perfused Rat Kidney. Pharm Res 14, 86–90 (1997). https://doi.org/10.1023/A:1012063602856

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012063602856

Navigation